- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $170M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $211M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $125M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $105M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $286M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $263M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.19B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.07B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.14B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.54B sh |
| Capex | Q1 2025 · Mar 31, 2024 | $8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$150M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.86B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.99B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $27M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $166M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$165M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$193M |